Axsome Therapeutics Receives FDA Complete Response Letter for New Drug Application for AXS-07 for the Acute Treatment of Migraine

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

New York ,United States ,Americans ,American ,Herriot Tabuteau ,Axsome Mo ,Mark Jacobson ,Centers For Disease ,American Migraine Foundation ,Prnewswire Axsome Therapeutics Inc ,Axsome Therapeutics Inc ,Drug Administration ,Nasdaq ,Complete Response Letter ,New Drug Application ,Chief Executive Officer ,Disease Control ,American Migraine ,Molecular Solubility Enhanced Inclusion Complex ,Axsome Therapeutics ,Business ,Health ,Pr Newswire ,Clinical Trials ,Migraine ,